Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cells.

The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cells. Prostate. 1996 Sep; 29(3):177-82.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.